President Biden has implemented a $35 insulin copay cap in Medicare and proposed extending it to people outside of Medicare. This follows a program initiated by former President Trump, where private Medicare drug plans could voluntarily cap insulin copays at $35. Additionally, Biden’s administration has lowered prices for hearing aids and inhalers, with inhalers now capped at $35 for most Americans. The Inflation Reduction Act, starting next year, will cap prescription drug costs for seniors at $2,000 annually. Medicare can now negotiate prices for select expensive, widely-used drugs, a move expected to save lives. Every single Republican in Congress voted against drug price negotiation, a $35 price cap on insulin, and a $2,000 cap on out-of-pocket prescription costs for seniors.
Starting next year, President Biden’s Inflation Reduction Act will cap prescription drug costs for seniors at $2,000 a year – putting money back in their pockets instead of Big Pharma’s.
Trump made promises about lowering drug prices, but President Biden and @HouseDemocrats ACTUALLY GOT IT DONE. Every single Republican in Congress voted against drug price negotiation, a $35 price cap on Insulin, and a $2000 cap on out-of-pocket Rx costs for seniors. https://t.co/6ufi8Xsh9W
Under the leadership of @POTUS Biden, we lowered insulin prices, hearing aid prices and now inhaler prices. Inhalers will now be capped at $35 for most Americans! #PeopleOverPolitics https://t.co/PCfQuUftR3
For years, Big Pharma and its army of lobbyists fiercely opposed allowing Medicare to negotiate drug prices, keeping prices sky-high. But thanks to @POTUS, Medicare can now negotiate prices for a select number of very expensive, widely-used drugs. This will save lives.
Trump claims credit for Biden’s insulin price cap-CNBC
Trump started a program where private Medicare drug plans could cap insulin copays voluntarily at $35. Biden has required a $35 insulin copay cap in Medicare and proposed extending it to people outside of Medicare. https://t.co/grKeuv7NXD